Comparative activity of ampicillin and seven cephalosporins against group D streptococci
- 1 October 1974
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 27 (10) , 828-831
- https://doi.org/10.1136/jcp.27.10.828
Abstract
Minimum inhibitory concentrations have been determined for ampicillin and seven cephalosporins against 93 strains of group D streptococci isolated recently from clinical material. Ampicillin was much the most active compound (modal MIC = 1·6 μg/ml); cephaloridine, cephacetrile, and cefazolin had a modal MIC of 25 μg/ml, while corresponding figures for cephalothin, cephradine, cephalexin, and cefoxitin were 50, 100, 200, and 800 μg/ml, respectively. Thus, none of the newer cephalosporins is an improvement in respect to activity against enterococci over existing compounds, and ampicillin remains overwhelmingly the β-lactam antibiotic of choice for the treatment of infections by such organisms. Pharmacokinetic considerations, however, indicate that certain cephalosporins, for instance, cephaloridine, cefazolin, and cephanone, may be worthy of further study in view of possible synergy with aminoglycoside antibiotics.Keywords
This publication has 22 references indexed in Scilit:
- Newer β-lactam antibioticsInfection, 1974
- Cefoxitin, a New Semi-synthetic Cephamycin: An In-vitro and In-vivo Comparison with CephalothinBMJ, 1973
- Drug susceptibility/resistance pattern of gram-negative uropathogens to seven cephalosporinsThe Lancet Healthy Longevity, 1973
- Cephacetrile: Clinical Evaluation in 27 PatientsAntimicrobial Agents and Chemotherapy, 1973
- Cephanone: In Vitro Antibacterial Activity and Pharmacology in Normal Human VolunteersAntimicrobial Agents and Chemotherapy, 1972
- Cephapirin: Pharmacology in Normal Human VolunteersThe Journal of Clinical Pharmacology and New Drugs, 1972
- Susceptibility of Group D Streptococcus (Enterococcus) to 21 Antibiotics In Vitro, with Special Reference to Species DifferencesThe Lancet Healthy Longevity, 1969
- ANTIMICROBIAL SUSCEPTIBILITY OF GROUP D HEMOLYTIC STREPTOCOCCI (ENTEROCOCCI)The Lancet Healthy Longevity, 1967
- New cephalosporin antibiotic--cephaloridine. Clinical and laboratory evaluationArchives of internal medicine (1960), 1967
- CEPHALOTHINThe Lancet Healthy Longevity, 1964